Jesús Herrera

2.7k citations
3 papers · 2.0k indexed · 1 hit paper · h-index 2
Topics
Helicobacter pylori-related gastroenterology studies (2 papers)Phytochemistry and Bioactive Compounds (1 paper)IL-33, ST2, and ILC Pathways (1 paper)

In The Last Decade

Jesús Herrera

2 papers receiving 2.0k citations

Hit Papers

Interleukin-1 polymorphisms associated with increased ris...2000202620082017200050010001.5k

Peers

Jesús Herrera
Comparison fields: 5 of 96
  • Surgery 1.4k
  • Immunology 941
  • Pulmonary and Respiratory Medicine 483
  • Molecular Biology 360
  • Oncology 265
Replace María Asunción García-González with:
María Asunción García-González Spain
Zhirong Zeng China
Takafumi Yuki Japan
Takao Maekita Japan
Cheryl Protheroe United States
Alkwin Wanders Sweden
Danielle Canioni France
Aliakbar Amirzargar Iran
Ioanna Delladetsima Greece
Jesús Herrera relative to María Asunción García-González Spain María Asunción García-González's profile →
Citations per field
00.5×3.8×
María Asunción García-González · 1×
Citations per year

Countries citing papers authored by Jesús Herrera

Since Specialization
Citations

This map shows the geographic impact of Jesús Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Herrera more than expected).

Fields of papers citing papers by Jesús Herrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Herrera. The network helps show where Jesús Herrera may publish in the future.

Co-authorship network of co-authors of Jesús Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Herrera. A scholar is included among the top collaborators of Jesús Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Herrera. Jesús Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Jesús Herrera

Jesús Herrera is a scholar working on Cancer Research, Immunology and Biomaterials, having authored 3 papers that have together received 2.0k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (2 papers), Phytochemistry and Bioactive Compounds (1 paper) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Immunology (941 citations), Surgery (1.4k citations) and Gastroenterology (146 citations). Jesús Herrera has collaborated with scholars based in Poland, United Kingdom and United States. Frequent co-authors include Maureen P. Martin, Charles S. Rabkin, Emad El‐Omar, Jolanta Lissowska, Mary Carrington, Howard A. Young, Jay H. Bream, Kenneth E.L. McColl, George Lanyon and N. Rothman. Their work appears in journals such as Nature and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026